產(chǎn)品描述: | AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM. |
靶點(diǎn): |
MEK1:7 nM (IC50);MEK2:7 nM (IC50);ERK;?MEK |
體內(nèi)研究: |
In tumour xenograft models, AZD8330 demonstrates dose-dependent tumour growth inhibition of approximately 90% at tolerated doses (1.0 mg/kg once daily [OD]) |
參考文獻(xiàn): |
1. Cohen RB, et al. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9. 2. Baranski Z, et al. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes Cancer. 2015 Nov;6(11-12):503-12. |
溶解性: |
DMSO : ≥ 100 mg/mL (216.81 mM) |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.168 ml |
10.841 ml |
21.681 ml |
5 mM |
0.434 ml |
2.168 ml |
4.336 ml |
10 mM |
0.217 ml |
1.084 ml |
2.168 ml |
50 mM |
0.043 ml |
0.217 ml |
0.434 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。 |